Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin continuation versus discontinuation after spontaneous lobar intracerebral hemorrhage
2024-511465-11-00Phase 3Authorised
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, open-label trial of simvastatin and atorvastatin in intracerebral hemorrhage (ICH) (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoints: Recurrent symptomatic intracerebral hemorrhage and Major adverse cardiac and cerebrovascular events. Planned start Nov 2024; status: authorised.
02
Drugs
simvastatinatorvastatin
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2024-511465-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511465-11-00.